• facebook
  • linkedin
  • youtube

Ukuvela kwe-SARS-CoV-2 B.1.1.7 Umnombo-

EUnited States, nge-29 kaDisemba 2020-NgoJanuwari 12, 2021

Ehlotyeni E. Galloway, PhD 1;Prabasaj Paul, PhD 1;UDuncan R. MacCannell, PhD 2;UMichael A. Johansson, PhD 1;

UJohn T. Brooks, MD 1;UAdam MacNeil, PhD 1;URachel B. Slayton, PhD 1;Suxiang Tong, PhD 1;Benjamin J. Silk, PhD 1;UGregory L. Armstrong, MD 2;

UMateyu Biggerstaff, iScD 1;UVivien G. Dugan, PhD

NgoJanuwari 15, 2021, le ngxelo yathunyelwa njengeMMWRUkukhutshwa kwangethuba kwiwebhusayithi yeMMWR (https://www.cdc.gov/mmwr).

NgoDisemba 14, 2020, iUnited Kingdom yanika ingxeloi-SARS-CoV-2 eyahlukileyo yenkxalabo (VOC), umnombo B.1.1.7,ikwabizwa ngokuba yi-VOC 202012/01 okanye 20I/501Y.V1.*B.1.1.7 ukwahluka kuqikelelwa ukuba kwavela ngoSeptemba2020 kwaye ngokukhawuleza ibe yeyona nto ijikelezayoUkwahluka kwe-SARS-CoV-2 eNgilani (1).B.1.1.7 iye yabaichongiwe kumazwe angaphezu kwama-30, kubandakanya ne-United States.NjengokokaJanuwari 13, 2021, malunga neemeko ezingama-76 ze-B.1.1.7 ziyeIfunyenwe kumazwe ali-12 ase-US.Ubungqina obuninzizibonisa ukuba i-B.1.1.7 isasazeke ngokufanelekileyo kunokuba zinjaloezinye iintlobo zeSARS-CoV-2 (1-3).Indlela engumzekelo yelo mahluko e-US ubonisa ukukhula okukhawulezayo ekuqaleni kuka-2021,ibe ngowona mahluko uphambili ngoMatshi.YandisiweUsulelo lwe-SARS-CoV-2 lunokusongela ukhathalelo lwempilo olunzimaizibonelelo, zifuna ukuphunyezwa okwandisiweyo nokungqongqoyezicwangciso zempilo yoluntu (4), kunye nokunyusa ipesenti yeUkhuselo loluntu olufunekayo kulawulo lobhubhane.Ukuthathaamanyathelo okunciphisa usulelo ngoku anokunciphisa amandlaimpembelelo ye-B.1.1.7 kunye nokuvumela ixesha elibalulekileyo lokwandisa isitofu sokugonyaukhuseleko.Ngokudibeneyo, uphononongo oluphuculweyo lwe-genomickudityaniswe nokuthotyelwa okuqhubekayo noluntu olusebenzayoamanyathelo ezempilo, kubandakanywa ugonyo, umgama ngokwasemzimbeni,ukusetyenziswa kweemaski, ucoceko lwezandla, kunye nokubekwa wedwa kunye nokuvalelwa yedwa, kuya kuba njaloKubalulekile ukunqanda ukusasazeka kwe-SARS-CoV-2, intsholongwaneebangela isifo se-coronavirus ngo-2019 (COVID-19).Ubuchuleuvavanyo lwabantu abangenazo iimpawu kodwa kumngcipheko ophezulu wokuusulelo, olunje ngabo bavezwe kwi-SARS-CoV-2 okanye abanayouqhagamshelwano rhoqo olungenakuthintelwa noluntu, lubonelela ngenyeithuba lokunciphisa ukusasazeka okuqhubekayo.

Ukuhlolwa kwe-genomic yehlabathi kunye ne-shar evulekileyo yomthombo ovulekileyoUlandelelwano lwejenome yentsholongwane luququzelele kufutshane nexesha lokwenyaniukufunyanwa, ukuthelekisa, kunye nokulandelwa kokuvela kwe-SARS-CoV-2ezahlukeneyo ezinokwazisa iinzame zempilo yoluntu ukulawulaisifo esikho elizweni jikelele.Ngexa ezinye iinguqulelo kwijenome yentsholongwanevela kwaye emva koko uhlehle, abanye banokunikezela ngokukhetha i-advanItheyiji kulwahlulo, kubandakanywa nokudluliselwa okongeziweyo, ukuzeuhlobo olunjalo lunokulawula ngokukhawuleza ezinye iinguqulelo ezijikelezayo.

Kwangoko kubhubhane, ukwahluka kwe-SARS-CoV-2 equlatheukuguqulwa kwe-D614G kwiprotheyini ye-spike (S) eyandayoI-receptor ebophelelayo ngokukhawuleza yaba yinto elawulayo kwabaninziimimandla yejografi (5,6).Ekwindla ka-2020, amazwe amaninzi axele ukuba abonileUkwahluka kwe-SARS-CoV-2 okusasazeka ngokufanelekileyo.Ukwengezaukuya ku-B.1.1.7 ukwahluka, ukwahluka okuphawulekayo kubandakanya i-B.1.351Umnombo ofunyenwe okokuqala eMzantsi Afrika kunye nowasanda kuchongwaB.1.1.28 isolotyana (lithiywe ngokutshaP.1) ichongiwe kubahambi abaneukusuka eBrazil ngexesha lovavanyo lwesiqhelo eHaneda (Tokyo)kwisikhululo seenqwelomoya.§ Ezi zantlukwano ziphethe iqela leenkwenkwezi ze-genetic mutations, kubandakanywa kwi-S protein receptor-binding domain,eyimfuneko ekubopheleleni kwiseli ye-angiotensin-ukuguqula i-enzyme-2 (ACE-2) i-receptor ukuququzelela intsholongwaneukungena.Ubungqina bubonisa ukuba ezinye iinguqulelo zemfuza ezifunyenwe kweziUkwahluka kunokunikezela kungekuphela nje ukosulela kodwainokuchaphazela ukusebenza koxilongo lwexesha lokwenyaniumva ukhuphelo-polymerase chain reaction (RT-PCR)iimvavanyokunye nokunciphisa ukungenwa kwi-neutraizing antibodies(2,3,5-10).Ingxelo yetyala yakutsha nje ibhale ityala lokuqala leUkosulelwa kwakhona kwe-SARS-CoV-2 eBrazil ngohlobo lwe-SARS-CoV-2ebiqulathe uguqulo lwe-E484K,** ebonisiweyoukunciphisa ukungathathi hlangothi nge-convalescent sera kunye ne-monoclonalamajoni omzimba (9,10).

Le ngxelo igxile ekuveleni kokwahluka kwe-B.1.1.7eUnited States.Ukusukela nge-12 kaJanuwari 2021, akukho namnyeB.1.351 okanye P.1 ezahlukeneyo ziye zabhaqwa kwiAmazwe Amanyene.Ngolwazi malunga nokuvela kwe-SARS-CoV-2ukwahluka kwenkxalabo, iCDC igcina iphepha lewebhu elinikezelweyoukubonelela ngolwazi ngezinto ezahlukeneyo ze-SARS-CoV-2 ezivelayo.††

 B.1.1.7 umnombo (20I/501Y.V1)

Ukwahlukana kwe-B.1.1.7 kuthwala utshintsho kwiprotheni ye-S(N501Y) echaphazela ukuhambelana kwe-receptor-bindingithambeka.Olu tshintsho lunezinye ii-13 ze-B.1.1.7 lineage-definingmutations (Itheyibhile), ezininzi zazo zikwiprotheni ye-S,kubandakanywa ukucinywa kwizithuba 69 kunye 70 (del69-70) ukubazavela ngokuzenzekelayo kwezinye iinguqulelo ze-SARS-CoV-2 kwaye zinjaloi-hypothesized ukwandisa ukudluliselwa (2,7).Ukucimakwizikhundla ze-69 kunye ne-70 ibangela ukusilela kwithagethi ye-S-gene (SGTF)ubuncinane kwi-RT-PCR enye-Uvavanyo olusekwe kuxilongo (okt, kunye neThermoFisher Taq Path COVID-19 assay, i-B.1.1.7 variimbovane kunye nezinye izinto ezahlukeneyo kunye nedel69-70 ivelisa i-negativeisiphumo se-S-gene ekujoliswe kuyo kunye nesiphumo esihle kwezinye ezimbiniekujoliswe kuko);I-SGTF isebenze njengommeli e-United Kingdomukuchonga amatyala B.1.1.7 (1).Ubungqina obuninzi bubonisa ukuba i-B.1.1.7 ingaphezuluisasazeke ngokufanelekileyo xa kuthelekiswa nezinye i-SARS-CoV-2ezahlukeneyo ezijikeleza eUnited Kingdom.imimandla UK ngeinxalenye ephezulu ye-B.1.1.7 yolandelelwano ibe nobhubhani okhawulezayoukukhula kunezinye iindawo, ukuxilongwa kwe-SGTF kwandangokukhawuleza kune-non-SGTF yoxilongo kwiindawo ezifanayo, kunye ainani eliphezulu labafowunelwa bosulelwe zizigulane zesalathisokunye nosulelo lwe-B.1.1.7 kunezigulana ezinesifoezinye iinguqulelo (1,3).I-variant B.1.1.7 inamandla okunyusa i-pan yase-USi-demic trajectory kwiinyanga ezizayo.Ukubonisa le mpembelelo,kwaphuhliswa imodeli yekhompatimenti elula, eyahluka-mbini.Ukuxhaphaka kwangoku kwe-US ye-B.1.1.7 phakathi kwabo bonke abajikelezayoiintsholongwane ayaziwa kodwa kucingelwa ukuba <0.5% ngokusekelwe kwiinani eliqingqiweyo leemeko ezichongiweyo kunye nedatha yeSGTF (8).Kubaimodeli, iingqikelelo zokuqala zibandakanya ukuxhaphaka kwe-B.1.1.7ye-0.5% phakathi kwalo lonke usulelo, ukhuseleko lwe-SARS-CoV-2 ukusukausulelo lwangaphambili lwe-10%-I-30%, ukuzala okuguquguqukayo kwexeshainombolo (R t ) ye-1.1 (encitshisiwe kodwa yanda usasazo)okanye 0.9 (ukunciphisa uthumelo) kwizinto ezahlukeneyo ezikhoyo, kunye nezehlo ezixeliweyo zamatyala angama-60 kubantu abayi-100,000 ngosuku.NgoJanuwari 1, 2021. Olu qikelelo alumeli ngokuthe ngqonayiphi na indawo eyodwa yase-US, kodwa endaweni yoko, bonisa ulungelelwaniso lweiimeko eziqhelekileyo kwilizwe liphela.Utshintsho kwi-R t phezuixesha elibangelwa kukhuseleko olufunyenweyo kunye nokwanda kwe-prevaI-lence ye-B.1.1.7, yenziwa imodeli, kunye ne-B.1.1.7 R t ecingelwayo.ukuba ibe yi-1.5 amaxesha ngamaxesha i-R t yokwahluka kwangoku, ngokusekelwe kwiuqikelelo lokuqala oluvela eUnited Kingdom (1,3).Okulandelayo, impembelelo enokubakho yogonyo yenziwa imodelikucingelwa ukuba idosi yesitofu sokugonya esi-1 sesigidi sasetyenziswa ngokweusuku oluqala nge-1 kaJanuwari 2021, kwaye loo 95% yokugonywayafunyanwa kwiintsuku ezili-14 emva kokufumana iidosi ezi-2.Ngokukodwa,ukungakhuseleki ngokuchasene nosulelo nokuba kukwahluka kwangoku okanyeB.1.1.7 ukwahluka kwacingelwa, nangona ukusebenza kunyeixesha lokukhuselwa kusulelo lihlala lingaqinisekanga,kuba ezi yayingezizo isiphelo sokuqala solingo lwezonyangokwizitofu zokuqala zokugonya.Kulo mzekelo, ukuxhaphaka kwe-B.1.1.7 ekuqaleni kuphantsi, kodwa ngenxa yokubaiyasulela ngakumbi kuneyantlukwano yangoku, iyabonisaukukhula okukhawulezayo ekuqaleni kuka-2021, ibe yeyona variri iphambiliimbovane ngoMatshi (Umfanekiso 1).Nokuba usasazo lwangokuukwahluka kuyanda (i-R yokuqala = 1.1) okanye iyancipha kancinci(i-R t yokuqala = 0.9) ngoJanuwari, i-B.1.1.7 iqhuba utshintsho olukhulukwindlela yothumelo kunye nenqanaba elitsha lokucacisaukukhula.Ngogonyo olukhusela usulelo, iiindlela zobhubhani kwangethuba azitshintshi kwaye B.1.1.7 ukusasazekaisenzeka (Umfanekiso 2).Nangona kunjalo, emva kokuba i-B.1.1.7 ibe yi-eyona ndlela ibalaseleyo, ukuhanjiswa kwayo kwehliswe kakhulu.Isiphumo sokugonya ekunciphiseni usulelo kufutshaneixesha lalilelona likhulu kwimeko apho uthumelo lwalukuyosele iyancipha (i-R t yokuqala = 0.9) (Umfanekiso 2).Iinzame zakwangoko ukubainokunciphisa ukusasazeka kwe-B.1.1.7 eyahlukileyo, njenge-universal andukwanda kokuthotyelwa kwezicwangciso zokunciphisa impilo yoluntu,iyakuvumela ixesha elithe kratya logonyo oluqhubekayo ukufikelela phezuluUkungakhuseleki kwinqanaba labantu.

Ingxoxo

Okwangoku, akukho mmahluko owaziwayo kwiziphumo zeklinikhieyayanyaniswa nokwahluka okuchaziweyo kwe-SARS-CoV-2;nangona kunjalo,izinga eliphezulu losulelo liya kukhokelela kwiimeko ezininzi, ukwandainani labantu ngokubanzi abafuna ukhathalelo lweklinikhi, baqinaukuthothisa umthwalo kwinkqubo yokhathalelo lwempilo esele inengxaki,kwaye kubangele ukufa kwabantu abaninzi.Ucupho oluqhubekayo lwe-genomicukuchonga amatyala B.1.1.7, kunye nokuvela kwamanyeezahlukeneyo inkxalabo eUnited States, kubalulekile ukubaImpendulo yezempilo yoluntu kwi-COVID-19.Nangona iziphumo zeSGTFinokunceda ekuchongeni iimeko ezinokuthi zibe B.1.1.7 ezinokuqinisekiswangokulandelelanisa, ukuchonga iinguqu eziphambili ezingabonisiyoI-SGTF ixhomekeke kuphela kucupho olusekwe kulandelelwano.

 

 

 

Ubizo olwahlukileyo

Ukuchongwa kokuqala  

Utshintsho lweempawu

(iprotheni: utshintsho)

Inani lamatyala akhoyo aqinisekisiweyo ngokulandelelana Inombolo ye

amazwe ane

ulandelelwano

Indawo Umhla Amazwe Amanyene Ehlabathini lonke  
B.1.1.7 (20I/501Y.V1) Iunited kingdom NgoSeptemba 2020 ORF1ab: T1001I, A1708D, I2230T,

del3675-3677 SGF

S: del69-70 HV, del144 Y, N501Y,

A570D, D614G, P681H, T761I,

S982A, D1118H

ORF8: Q27stop, R52I, Y73C

N: D3L, S235F

76 15,369 36
B.1.351 (20H/501Y.V2) Mzantsi Afrika Okt 2020 ORF1ab: K1655N

E:P71L

N: T205I

S:K417N, E484K, N501Y, D614G,

A701V

0 415 13

 

P.1 (20J/501Y.V3 Brazil kunye Japan NgoJanuwari 2021 ORF1ab: F681L, I760T, S1188L,

K1795Q, del3675-3677 SGF, E5662D

S: L18F, T20N, P26S, D138Y, R190S,

I-K417T, E484K, N501Y, D614G,

H655Y, T1027I

ORF3a: C174G

ORF8: E92K

ORF9: Q77E

ORF14: V49L

N: P80R

0 35 2

 

Ushunqulelo: del = ukucinywa;E = iprotheyini yemvulophu;N = iprotheni ye-nucleocapsid;ORF = isakhelo sokufunda esivulekileyo;S = iprotein ye-spike.

Amava e-United Kingdom kunye neemodeli ze-B.1.1.7ezithiwe thaca kule ngxelo zibonisa impembelelo eyosulela ngakumbiUmahluko unokuba kwinani leemeko kubemi.Iukwanda kokugqithisela kolu tshintsho kufuna ngakumbiukuphunyezwa ngokungqongqo okudityanisiweyo kogonyo kunye ne-mitigaimilinganiselo ye-tion (umzekelo, umgama, ukugquma ubuso, kunye nococeko lwezandla)ukulawula ukusasazeka kwe-SARS-CoV-2.La manyathelo aya kubazisebenza ngakumbi ukuba ziqaliswe ngokukhawuleza kunokuba kamvaukucotha ukusasazeka kokuqala kokwahluka kwe-B.1.1.7.Iinzame zokulungisa inkqubo yokhathalelo lwempilo ukulungiselela utyando olongezelelekileyo kwiimekoiqinisekisiwe.Ukwandiswa kokugqithisela kwakhona kuthetha ukuba phezuluUgonyo olungaphezu kolulindelwe kufuneka lufikelelweukufikelela kwinqanaba elifanayo lolawulo lwezifo ukukhusela uluntuxa kuthelekiswa nokwahluka okungasuleleki kakhulu.Ngentsebenziswano nezemfundo, ishishini, urhulumente, indawo,tribal, kunye namaqabane asekuhlaleni, CDC kunye nezinye arhente federalbaququzelela kwaye baphucula ucupho lwe-genomic kunyeiinzame zokulinganiswa kwentsholongwane kulo lonke elase-United States.I-CDCilungelelanisa iinzame zolandelelwano zase-US nge-SARS-CoV-2Ulandelelwano lweMpendulo yoNgxamiseko kwiMpilo yoLuntu,I-Epidemiology, kunye noVavanyo (SPHERES)§§ikhonsortium,equka malunga namaziko athatha inxaxheba ali-170 kwaye ikhuthaza ukwabelana ngedatha okuvulelekileyo ukuququzelela ukusetyenziswa kwe-SARS-CoV-2idatha yolandelelwano.Ukulandelela ukuvela kwentsholongwane ye-SARS-CoV-2, i-CDC iukuphumeza uhlolo lwe-genomic olunezigaba ezininzi ukuqondaI-epidemiologic, i-immunologic, kunye neenkqubo zendalekoezibumba iiphylogenies zentsholongwane (phylodynamics);Ukuqhambuka kwesikhokelouphando;kwaye uququzelele ubhaqo kunye neempawuUkosuleleka kwakhona okunokwenzeka, iimeko zokuphumelela kwesitofu sokugonya, kunyeiintlobo zentsholongwane ezikhulayo.NgoNovemba 2020, iCDC yasekwainkqubo yoHlolo lweSizwe lwe-SARS-CoV-2 (NS3).ukuphucula ukumelwa kwe-SARS-CoV-2 yasekhayaulandelelwano.Inkqubo isebenzisana ne-64 US yoluntuiilebhu zezempilo ukuxhasa inkqubo yokucupha i-genomic;I-NS3 ikwakha ingqokelela yeesampulu ze-SARS-CoV-2 akunye nolandelelwano lokuxhasa impendulo yempilo yoluntu kunye nesayensiuphando lokuvavanya impembelelo malunga notshintsho kwiamanyathelo akhoyo acetyiswayo ezonyango.CDC iyeUkwanekhontrakthi kunye nelebhu enkulu yeklinikhi yorhweboiitories zokulandelelana ngokukhawuleza amashumi amawaka e-SARS-CoV-2-imizekelo emihle nyanga nganye kwaye uxhase ngemali abafundi abasixhenxeamaziko ukuba enze uphononongo lwe-genomic ngokubambisanakunye nee-arhente zempilo zoluntu, ngoko ke ukongeza kakhuluukufumaneka kwedatha ye-genomic surveillance kwangexesha ukusuka phesheyaiunited States.Ukongeza kula malinge esizwe,uninzi lweearhente zempilo zikarhulumente nezengingqi zilandelelana

UMZO 1. Iindlela zezehlo ezilinganisiweyo* zokwahluka kwangoku kwe-SARS-CoV-2 kunye nokwahluka kwe-B.1.1.7,Ucinga ukuba akukho lugonyo loluntukunye nokuba ngu-R t = 1.1 (A) okanye u-R t = 0.9 (B) kwizinto ezahlukeneyo zangoku-EUnited States, ngoJanuwari-Epreli 2021

 

umfanekiso 1
umfanekiso 2
izifinyezo
umfanekiso 1

I-SARS-CoV-2 yokuqonda ngcono isifo sesifo sendawo kunyeukuxhasa impendulo yezempilo yoluntu kubhubhane.Izinto ezifunyanisiweyo kule ngxelo zixhomekeke kubuncinci imida emithathuiintetho.Okokuqala, ubukhulu bokunyuka kwe-transmissibileUnited States xa kuthelekiswa naleyo ibonwe kwiI-United Kingdom ihlala ingacacanga.Okwesibini, ukuxhaphaka kweB.1.1.7 e-United States nayo ayaziwa ngeli xesha, kodwaukufunyanwa kwezinto ezahlukeneyo kunye noqikelelo lokuxhaphaka kuya kuphuculangemizamo eyongeziweyo yokubeka esweni yase-US.Ekugqibeleni, i-mitiga yendawoAmanyathelo olawulo nawo aguquguquka kakhulu, akhokelela kukwahlukaR t .Iziphumo ezithile ezithiwe thaca apha zisekwe kukulinganisakwaye acinge ukuba akukho tshintsho kunciphiso ngaphaya kwe-1 kaJanuwari.Ukugqithiswa okwandisiweyo kwe-B.1.1.7 eyahlukileyo yemfazweuqhuba ngokungqongqo ukuphunyezwa kwezicwangciso-qhinga zempilo yoluntu ukuzeukunciphisa usulelo kunye nokunciphisa impembelelo enokubakho ye-B.1.1.7,ukuthenga ixesha elibalulekileyo lokwandisa ukhuseleko logonyo.ICDC'Sidatha yemodeli ibonisa ukuba ukusetyenziswa jikelele kunye nokwanda kokuthobelanakunye namanyathelo okunciphisa kunye nogonyo lubalulekileukunciphisa inani lamatyala amatsha kunye nokufa kakhulu kwiiinyanga ezizayo.Ngaphezu koko, uvavanyo lweqhinga lwabantu abangenayoiimpawu ze-COVID-19, kodwa ngoobani abasemngciphekweni owongeziweyousulelo nge-SARS-CoV-2, inika elinye ithuba lokuumda ukusasazeka okuqhubekayo.Ngokudibeneyo, uphononongo oluphuculweyo lwe-genomicintambo kudityaniswe nokwanda kokuthotyelwa kwempilo yoluntuizicwangciso zokunciphisa, kubandakanywa ugonyo, umgama womzimbaukusetyenziswa kweemaski, ucoceko lwezandla, kunye nokuzivalela yedwa,kuya kuba yimfuneko ekuthinteleni ukusasazeka kwe-SARS-CoV-2 kunyeukukhusela impilo yoluntu.

Imibulelo

Amalungu oLungelelaniso lweMpilo yoLuntu oluNgxamisekileyoIimpendulo, i-Epidemiology kunye ne-Surveillance consortium;karhulumente kunye nengingqiiilebhu zezempilo zoluntu;Umbutho weeLebhu zoLuntu lwezeMpilo;Iqela leempendulo leCDC COVID-19;Isebe leeNtsholongwane zokuphefumla,Ulwahlulo lweZifo zeNtsholongwane, i-CDC.Komidi yeKomidi yezoNyango zabahleli beJenali yezoNyango ukuze kubhengezwe ukuba kunokwenzekaukungqubana kwemidla.Akukho kungqubana kwemidla okunokuthi kubhengezwe.

Iimbekiselo

1. Impilo yoLuntu eNgilani.Uphando lwenoveli eyahlukileyo ye-SARS-CoV-2: ukwahluka kwenkxalabo 202012/01, ingcaciso ngobuchule 3. London, United Kingdom: Public Health England;2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/950823/Variant_of_Concern_VOC_202012_01_Technical_Briefing_3_-_England.pdf
2. Kemp SA, Harvey WT, Datir RP, et al.Ukuvela rhoqo kunye nokuhanjiswa kwe-SARS-CoV-2 spike kucinywe ΔH69/V70.i-bioRxiv[Ishicilelo kwangaphambili ifakwe kwi-intanethi kaJanuwari 14, 2021].https://www.biorxiv.org/content/10.1101/2020.12.14.422555v4
3. Volz E, Mishra S, Chand M, et al.Ugqithiso lwe-SARS-CoV-2 yomgca B.1.1.7 eNgilani: ulwazi olusuka kunxulumaniso lwedatha ye-epidemiological kunye nemfuzo.medRxiv [Ukushicilelwa kwangaphambili kufakwe kwi-intanethi kaJanuwari 4, 2021].https://www.medrxiv.org/content/10.1101/2020.12.30.20249034v2
4. Honein MA, Christie A, Rose DA, et al.;Iqela leempendulo leCDC COVID-19.Isishwankathelo sesikhokelo sezicwangciso zempilo yoluntu ukulungisa amanqanaba aphezulu osulelo loluntu lwe-SARS-CoV-2 kunye nokufa okunxulumeneyo, ngoDisemba 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1860–7.PMID:33301434 https://doi.org/10.15585/mmwr.2mm.
5. Volz E, Hill V, McCrone JT, et al.;I-COG-UK Consortium.Ukuphonononga iziphumo ze-SARS-CoV-2 spike ukuguqulwa kwe-D614G ekudluliselweni kunye ne-pathogenicity.Iseli 2021;184:64-75.e11.PMID:33275900 https://doi.org/10.1016/j.cell.2020.11.020
6. UKorber B, uFischer WM, uGnanakaran S, et al.;Iqela leSheffield COVID-19 Genomics.Ukulandelela utshintsho kwi-SARS-CoV-2 spike: ubungqina bokuba i-D614G yonyusa ukosuleleka kwentsholongwane ye-COVID-19.Iseli
2020;182:812–27.PMID:32697968 https://doi.org/10.1016/j.cell.2020.06.043
7. McCarthy KR, Rennick LJ, Namnulli S, et al.Ukucinywa kwendalo kwi-SARS-CoV-2 spike glycoprotein kuqhuba ukubaleka kwe-antibody.bioRxiv [Ushicilelo olungaphambili lufakwe kwi-intanethi ngoNovemba 19, 2020].https://www.biorxiv.org/content/
10.1101/2020.11.19.389916v18.IWashington NL, White S, Schibor KM, Cirulli ET, Bolze A, Lu JT.S iipateni zokuyeka imfuza kwiimvavanyo ze-SARS-CoV-2 zibonisa ukusasazeka kotshintsho lwe-H69del/V70del e-US.medRxiv [Ushicilelo olungaphambili lufakwe kwi-intanethi nge-30 kaDisemba 2020].https://www.medrxiv.org/content/10.1101/2020.12.24.20248814v1
9. Weisblum Y, Schmidt F, Zhang F, et al.Baleka kwii-antibodies ze-SARS-CoV-2 spike protein ezahlukeneyo.eLife 2020;9:e61312.PMID:33112236 https://doi.org/10.7554/eLife.61312
10. Greaney AJ, Loes AN, Crawford KHD, et al.Imephu ebanzi yotshintsho kwi-SARS-CoV-2 receptor-binding domain echaphazela ukuqondwa zii-polyclonal human serum antibodies.bioRxiv [Ushicilelo olungaphambili lufakwe kwi-intanethi kaJanuwari 4, 2021].https://www.biorxiv.org/content/10.1101/2020.12.31.425021v1


Ixesha lokuposa: Feb-11-2021